Quarterly Result30 Oct 2026, 06:31 pm
Corona Remedies Declares Q2 FY27 Unaudited Financial Results
AI Summary
Corona Remedies Ltd announced the outcome of its Board Meeting held today, wherein the Board approved the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026. The company will publish these results in an advertisement as per listing regulations. The financial results and limited review reports are also available on the company's website. The Board meeting commenced at 3:30 PM and concluded at 4:40 PM.
Key Highlights
- Board approved unaudited financial results for Q2 and H1 FY27.
- Results are standalone and consolidated.
- Limited review reports are enclosed.
- Results to be published in an advertisement.
- Results available on the company website.
Price Impact
More from CORONA